Midgard Science

remynd

Leuven, Belgium remynd.com From their website, Nov 2026

Work here? Claim this listing

About

remynd develops oral treatments for age-related neurodegenerative diseases, including Alzheimer’s disease, Huntington’s disease, and ALS-related mitochondrial dysfunction. It is based in the Arenberg Science Park in Leuven (Heverlee), Belgium, and has provided CRO services using proprietary mouse models.

Services

  • CRO services for neurodegenerative disease programs

    Assesses the effects of experimental Alzheimer’s and other neurodegenerative disease treatments in proprietary mouse models.

  • Alzheimer’s program

    Develops first-in-class oral treatments aimed at symptomatic benefit and disease modification by restoring synaptic function and reducing Aβ and tau pathology over time.

  • Huntington’s program

    Develops first-in-class oral treatments that restore cortico-striatal transmission by targeting oxidative stress.

  • Discovery program for ALS

    Addresses mitochondrial dysfunction as part of remynd’s discovery work in amyotrophic lateral sclerosis.

Capabilities

Assays and studies
  • Antibodies
  • Rodent models
  • In-vivo proof-of-concept
  • Symptomatic benefit assessment
  • Disease-modification assessment
Therapeutic areas
  • Alzheimer’s disease
  • Huntington’s disease
  • Amyotrophic lateral sclerosis (ALS)
  • Neurodegenerative diseases

Modalities and species

Modalities
Antibody
Species and models
Mouse models

Details

Type
CRO
Address
Geenslaan 1 BE-3001 Leuven (Heverlee) T
Sites
Leuven (Heverlee), Belgium
Serves
US, Europe, Japan
General enquiry
info@remynd.com on their site

Similar labs